Symbols / ABUS Stock $4.28 -2.62% Arbutus Biopharma Corporation

Healthcare • Biotechnology • United States • NMS
ABUS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NMS · United States
Market Cap 848.81M
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $4.39
Price $4.28
Change -2.62%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest ABUS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
14.08
+128.21%
6.17
-65.98%
18.14
-53.51%
39.02
Operating Revenue
14.08
+128.21%
6.17
-65.98%
18.14
-53.51%
39.02
Operating Expense
41.13
-45.98%
76.14
-20.83%
96.17
-5.93%
102.24
Research And Development
25.24
-53.29%
54.04
-26.68%
73.70
-12.69%
84.41
Selling General And Administration
15.89
-28.11%
22.11
-1.63%
22.48
+26.02%
17.83
General And Administrative Expense
15.89
-28.11%
22.11
-1.63%
22.48
+26.02%
17.83
Other Gand A
15.89
-28.11%
22.11
-1.63%
22.48
+26.02%
17.83
Total Expenses
41.13
-45.98%
76.14
-20.83%
96.17
-5.93%
102.24
Operating Income
-27.05
+61.34%
-69.97
+10.33%
-78.03
-23.43%
-63.22
Total Operating Income As Reported
-38.16
+50.00%
-76.32
+2.28%
-78.10
-19.32%
-65.46
EBITDA
-33.04
+51.70%
-68.40
+3.64%
-70.99
-14.75%
-61.86
Normalized EBITDA
-22.62
+63.52%
-62.01
+12.59%
-70.94
-19.02%
-59.60
Reconciled Depreciation
0.36
-73.70%
1.38
-1.71%
1.40
-1.61%
1.43
EBIT
-33.40
+52.13%
-69.78
+3.60%
-72.39
-14.39%
-63.29
Total Unusual Items
-10.42
-62.98%
-6.39
-14431.82%
-0.04
+98.05%
-2.25
Total Unusual Items Excluding Goodwill
-10.42
-62.98%
-6.39
-14431.82%
-0.04
+98.05%
-2.25
Special Income Charges
-10.44
-64.46%
-6.34
-9095.65%
-0.07
+96.91%
-2.23
Restructuring And Mergern Acquisition
11.11
+75.08%
6.34
+9095.65%
0.07
-96.91%
2.23
Net Income
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Pretax Income
-33.50
+52.09%
-69.92
+4.02%
-72.85
-12.05%
-65.01
Net Non Operating Interest Income Expense
3.97
-38.42%
6.45
+23.31%
5.23
+1022.10%
0.47
Interest Expense Non Operating
0.10
-29.20%
0.14
-70.15%
0.46
-73.41%
1.73
Net Interest Income
3.97
-38.42%
6.45
+23.31%
5.23
+1022.10%
0.47
Interest Expense
0.10
-29.20%
0.14
-70.15%
0.46
-73.41%
1.73
Interest Income Non Operating
4.07
-38.22%
6.58
+15.77%
5.69
+159.49%
2.19
Interest Income
4.07
-38.22%
6.58
+15.77%
5.69
+159.49%
2.19
Other Income Expense
-10.42
-62.98%
-6.39
-14431.82%
-0.04
+98.05%
-2.25
Gain On Sale Of Security
0.01
+128.57%
-0.05
-296.00%
0.03
+213.64%
-0.02
Tax Provision
—
0.00
0.00
-100.00%
4.44
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
+100.00%
-0.47
Net Income Including Noncontrolling Interests
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Net Income From Continuing Operation Net Minority Interest
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Net Income From Continuing And Discontinued Operation
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Net Income Continuous Operations
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Normalized Income
-23.08
+63.67%
-63.53
+12.75%
-72.81
-7.58%
-67.67
Net Income Common Stockholders
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-0.17
+55.26%
-0.38
+13.64%
-0.44
+4.35%
-0.46
Basic EPS
-0.17
+55.26%
-0.38
+13.64%
-0.44
+4.35%
-0.46
Basic Average Shares
191.60
+3.23%
185.61
+11.84%
165.96
+9.95%
150.94
Diluted Average Shares
191.60
+3.23%
185.61
+11.84%
165.96
+9.95%
150.94
Diluted NI Availto Com Stockholders
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Earnings From Equity Interest
—
—
—
—
Gain On Sale Of PPE
0.67
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
94.62
-28.16%
131.71
-8.79%
144.40
-26.11%
195.42
Current Assets
94.46
-25.81%
127.32
-3.57%
132.03
-12.65%
151.14
Cash Cash Equivalents And Short Term Investments
91.47
-25.40%
122.62
-2.68%
126.00
-14.23%
146.91
Cash And Cash Equivalents
18.01
-50.43%
36.33
+38.22%
26.29
-14.59%
30.78
Other Short Term Investments
73.46
-14.87%
86.29
-13.46%
99.72
-14.14%
116.14
Receivables
1.45
-39.93%
2.41
+35.64%
1.78
+31.36%
1.35
Accounts Receivable
1.45
-39.93%
2.41
+35.64%
1.78
+31.36%
1.35
Prepaid Assets
—
—
—
—
Other Current Assets
1.54
-32.66%
2.28
-46.23%
4.25
+47.81%
2.87
Total Non Current Assets
0.16
-96.31%
4.39
-64.51%
12.37
-72.06%
44.28
Net PPE
0.03
-99.27%
4.36
-28.46%
6.09
-10.63%
6.81
Gross PPE
0.24
-98.59%
17.35
-3.54%
17.99
+2.13%
17.61
Accumulated Depreciation
-0.21
+98.36%
-13.00
-9.21%
-11.90
-10.17%
-10.80
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.24
-48.64%
0.48
+21.99%
0.39
+0.00%
0.39
Other Properties
—
8.29
-8.03%
9.01
+4.34%
8.63
Leases
0.00
-100.00%
8.59
+0.00%
8.59
+0.00%
8.59
Investments And Advances
—
0.00
-100.00%
6.28
-83.18%
37.36
Other Non Current Assets
0.13
+282.35%
0.03
—
0.10
Total Liabilities Net Minority Interest
18.04
-47.46%
34.34
-10.53%
38.38
-34.46%
58.57
Current Liabilities
6.01
-61.54%
15.62
-30.55%
22.49
-31.56%
32.86
Payables And Accrued Expenses
4.82
-36.29%
7.56
-26.36%
10.27
-35.92%
16.03
Payables
1.17
-49.35%
2.32
-28.14%
3.22
-8.44%
3.52
Accounts Payable
1.17
-49.35%
2.32
-28.14%
3.22
-8.44%
3.52
Current Accrued Expenses
3.65
-30.53%
5.25
-25.54%
7.05
-43.66%
12.51
Current Debt And Capital Lease Obligation
0.55
+13.25%
0.48
+13.65%
0.42
+14.25%
0.37
Current Capital Lease Obligation
0.55
+13.25%
0.48
+13.65%
0.42
+14.25%
0.37
Current Deferred Liabilities
0.00
-100.00%
7.57
-35.79%
11.79
-28.35%
16.46
Current Deferred Revenue
0.00
-100.00%
7.57
-35.79%
11.79
-28.35%
16.46
Other Current Liabilities
0.64
—
—
—
Total Non Current Liabilities Net Minority Interest
12.04
-35.72%
18.72
+17.78%
15.90
-38.17%
25.71
Long Term Debt And Capital Lease Obligation
0.20
-75.31%
0.81
-39.99%
1.34
-26.01%
1.81
Long Term Capital Lease Obligation
0.20
-75.31%
0.81
-39.99%
1.34
-26.01%
1.81
Non Current Deferred Liabilities
0.00
-100.00%
2.86
0.00
-100.00%
6.00
Non Current Deferred Revenue
0.00
-100.00%
2.86
0.00
-100.00%
6.00
Other Non Current Liabilities
11.84
-21.37%
15.05
+3.44%
14.55
-18.68%
17.90
Stockholders Equity
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Common Stock Equity
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Capital Stock
1,421.43
+0.81%
1,410.03
+4.46%
1,349.82
+2.36%
1,318.74
Common Stock
1,421.43
+0.81%
1,410.03
+4.46%
1,349.82
+2.36%
1,318.74
Preferred Stock
—
—
—
—
Share Issued
192.53
+1.35%
189.96
+11.83%
169.87
+7.88%
157.46
Ordinary Shares Number
192.53
+1.35%
189.96
+11.83%
169.87
+7.88%
157.46
Additional Paid In Capital
83.32
+1.55%
82.05
+0.96%
81.27
+12.24%
72.41
Retained Earnings
-1,380.07
-2.49%
-1,346.57
-5.48%
-1,276.65
-6.05%
-1,203.80
Gains Losses Not Affecting Retained Earnings
-48.10
+0.08%
-48.13
+0.59%
-48.42
+4.09%
-50.49
Other Equity Adjustments
-48.10
+0.08%
-48.13
+0.59%
-48.42
+4.09%
-50.49
Total Equity Gross Minority Interest
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Total Capitalization
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Working Capital
88.45
-20.81%
111.70
+1.97%
109.54
-7.39%
118.28
Invested Capital
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Total Debt
0.75
-42.13%
1.29
-27.09%
1.77
-19.16%
2.19
Capital Lease Obligations
0.75
-42.13%
1.29
-27.09%
1.77
-19.16%
2.19
Net Tangible Assets
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Tangible Book Value
76.58
-21.35%
97.37
-8.16%
106.02
-22.53%
136.85
Available For Sale Securities
—
—
—
37.36
Held To Maturity Securities
—
0.00
-100.00%
6.28
-83.18%
37.36
Investmentin Financial Assets
—
0.00
-100.00%
6.28
-83.18%
37.36
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-39.64
+38.88%
-64.85
+24.54%
-85.94
-143.06%
-35.36
Cash Flow From Continuing Operating Activities
-39.64
+38.88%
-64.85
+24.54%
-85.94
-143.06%
-35.36
Net Income From Continuing Operations
-33.50
+52.09%
-69.92
+4.02%
-72.85
-4.89%
-69.46
Depreciation Amortization Depletion
0.36
-73.70%
1.38
-1.71%
1.40
-1.61%
1.43
Depreciation
0.36
-73.70%
1.38
-1.71%
1.40
-1.61%
1.43
Depreciation And Amortization
0.36
-73.70%
1.38
-1.71%
1.40
-1.61%
1.43
Other Non Cash Items
-3.22
-742.12%
0.50
+114.99%
-3.34
+9.60%
-3.70
Stock Based Compensation
6.95
-22.62%
8.99
-3.39%
9.30
+29.50%
7.18
Asset Impairment Charge
2.81
+1583.23%
0.17
0.00
—
Operating Gains Losses
-0.67
—
-0.02
—
Net Foreign Currency Exchange Gain Loss
—
—
—
—
Gain Loss On Sale Of PPE
-0.67
0.00
+100.00%
-0.02
0.00
Change In Working Capital
-10.02
-254.29%
-2.83
+84.48%
-18.23
-162.35%
29.24
Change In Receivables
1.38
+317.22%
-0.63
-49.29%
-0.42
+6.40%
-0.45
Changes In Account Receivables
1.38
+317.22%
-0.63
-49.29%
-0.42
+6.40%
-0.45
Change In Prepaid Assets
1.70
-26.11%
2.30
+343.69%
-0.94
-138.81%
2.43
Change In Payables And Accrued Expense
-2.10
+22.24%
-2.71
+52.99%
-5.76
-210.39%
5.22
Change In Payable
—
—
—
5.22
Change In Account Payable
—
—
—
5.22
Change In Other Working Capital
-10.43
-668.90%
-1.36
+87.27%
-10.66
-147.49%
22.45
Change In Other Current Liabilities
-0.56
-29.53%
-0.43
+3.15%
-0.44
-9.63%
-0.41
Investing Cash Flow
15.58
-32.11%
22.95
-54.80%
50.77
+167.75%
-74.94
Cash Flow From Continuing Investing Activities
15.58
-32.11%
22.95
-54.80%
50.77
+167.75%
-74.94
Net PPE Purchase And Sale
0.36
+300.00%
-0.18
+81.58%
-0.99
-92.97%
-0.51
Purchase Of PPE
0.00
+100.00%
-0.18
+81.94%
-1.01
-96.88%
-0.51
Sale Of PPE
0.36
0.00
-100.00%
0.02
0.00
Capital Expenditure
—
-0.18
+81.94%
-1.01
-96.88%
-0.51
Net Investment Purchase And Sale
15.22
-34.22%
23.13
-55.31%
51.76
+169.54%
-74.43
Purchase Of Investment
-140.06
+1.02%
-141.51
-75.77%
-80.51
+38.27%
-130.43
Sale Of Investment
155.28
-5.69%
164.64
+24.47%
132.27
+136.20%
56.00
Financing Cash Flow
5.72
-89.00%
52.00
+69.66%
30.65
-3.67%
31.81
Cash Flow From Continuing Financing Activities
5.72
-89.00%
52.00
+69.66%
30.65
-3.67%
31.81
Net Common Stock Issuance
0.00
-100.00%
44.12
+47.81%
29.85
+46.88%
20.32
Proceeds From Stock Option Exercised
5.72
-27.33%
7.87
+890.31%
0.80
-93.08%
11.49
Changes In Cash
-18.34
-281.65%
10.09
+323.52%
-4.52
+94.25%
-78.48
Effect Of Exchange Rate Changes
0.01
+128.57%
-0.05
-296.00%
0.03
+213.64%
-0.02
Beginning Cash Position
36.33
+38.22%
26.29
-14.59%
30.78
-71.84%
109.28
End Cash Position
18.01
-50.43%
36.33
+38.22%
26.29
-14.59%
30.78
Free Cash Flow
-39.64
+39.05%
-65.03
+25.20%
-86.94
-142.40%
-35.87
Amortization Of Securities
-2.35
+25.07%
-3.13
-42.76%
-2.20
-3966.67%
-0.05
Common Stock Issuance
0.00
-100.00%
44.12
+47.81%
29.85
+46.88%
20.32
Issuance Of Capital Stock
0.00
-100.00%
44.12
+47.81%
29.85
+46.88%
20.32
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category